Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
Condition: Malaria Interventions: Drug: Sulfadoxine-pyrimethamine (SP); Drug: Dihydroartemisinin-piperaquine (DP) Sponsors: Grant Dorsey, M.D, Ph.D.; National Institutes of Health (NIH); Infectious Diseases Research Collaboration, Uganda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials